Johnson Financial Group Inc (Wisconsin)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Johnson Financial Group Inc (Wisconsin)'s IBB Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) reduced its iShares Biotechnology ETF (IBB) stake by 50% in Q2 2026, selling an estimated $21.5K and leaving 125 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #546.
Johnson Financial Group Inc (Wisconsin) first reported a position in IBB in Q4 2017 and has held it in 18 quarters since. The position peaked at $372K in Q4 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) held 125 shares of iShares Biotechnology ETF worth $23.8K as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) sold 125 iShares Biotechnology ETF shares in Q2 2026, an estimated $21.5K.
- iShares Biotechnology ETF made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #546 holding.
- Johnson Financial Group Inc (Wisconsin) first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 18 quarters since.
- Johnson Financial Group Inc (Wisconsin)'s iShares Biotechnology ETF position peaked at $372K in Q4 2022.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.